Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study

Background: Information regarding short-term vital prognosis in patients with heart failure at advanced stages of the disease is scarce. Objective: To develop a three-month mortality predictive model for patients with advanced heart failure. Methods: Prospective observational study carried out in pr...

Full description

Bibliographic Details
Main Authors: Miguel Angel Muñoz, Esther Calero, Julio Duran, Elena Navas, Susana Alonso, Nuria Argemí, Marta Casademunt, Patricia Furió, Elena Casajuana, Nuria Torralba, Nuria Farre, Rosa Abellana, José-Maria Verdú-Rotellar, On behalf of HADES Study
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/9/2280
_version_ 1797504274366726144
author Miguel Angel Muñoz
Esther Calero
Julio Duran
Elena Navas
Susana Alonso
Nuria Argemí
Marta Casademunt
Patricia Furió
Elena Casajuana
Nuria Torralba
Nuria Farre
Rosa Abellana
José-Maria Verdú-Rotellar
On behalf of HADES Study
author_facet Miguel Angel Muñoz
Esther Calero
Julio Duran
Elena Navas
Susana Alonso
Nuria Argemí
Marta Casademunt
Patricia Furió
Elena Casajuana
Nuria Torralba
Nuria Farre
Rosa Abellana
José-Maria Verdú-Rotellar
On behalf of HADES Study
author_sort Miguel Angel Muñoz
collection DOAJ
description Background: Information regarding short-term vital prognosis in patients with heart failure at advanced stages of the disease is scarce. Objective: To develop a three-month mortality predictive model for patients with advanced heart failure. Methods: Prospective observational study carried out in primary care and a convalescence community facility. Heart failure patients either New York Heart Association (NYHA) III with at least two HF hospitalizations during the previous six months or NYHA IV with/without previous recent hospitalization were included in the study. Multivariable predictive models using Cox regression were performed. Results: Of 271 patients included, 55 (20.3%) died during the first three months of follow-up. Mean age was 84.2 years (SD 8.3) and 59.8% were women. Predictive model including NT-proBNP had a C-index of 0.78 (95% CI 0.71; 0.85) and identified male gender, low body mass index, high potassium and NT-proBNP levels, and moderate-to-severe dependence for daily living activities (Barthel index < 40) as risk factors of mortality. In the model without NT-proBNP, C index was 0.72 (95% CI 0.64; 0.79) and, in addition to gender, body mass index, low Barthel index, and severe reductions in glomerular filtration rate showed the highest predictive hazard ratios for short-term mortality. Conclusions: In addition to age, male gender, potassium levels, low body mass index, and low glomerular filtration, dependence for activities of daily living add strong power to predict mortality at three months in patients with advanced heart failure.
first_indexed 2024-03-10T04:02:19Z
format Article
id doaj.art-553506de8a394ece9e5d2e2518669a96
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T04:02:19Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-553506de8a394ece9e5d2e2518669a962023-11-23T08:30:03ZengMDPI AGJournal of Clinical Medicine2077-03832022-04-01119228010.3390/jcm11092280Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades StudyMiguel Angel Muñoz0Esther Calero1Julio Duran2Elena Navas3Susana Alonso4Nuria Argemí5Marta Casademunt6Patricia Furió7Elena Casajuana8Nuria Torralba9Nuria Farre10Rosa Abellana11José-Maria Verdú-Rotellar12On behalf of HADES StudyGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainBellvitge University Hospital, Institut Català de la Salut, 08921 Barcelona, SpainClinica Sant Antoni (Institut Medic i de Rehabilitació), 08038 Barcelona, SpainInstitut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainHospital del Mar Medical Research Institute, 08003 Barcelona, SpainDepartament de Fonaments Clínics-Bioestadística, School of Medicine, Universitat de Barcelona, 08007 Barcelona, SpainGerencia Territorial de Barcelona (Primary Healthcare), Institut Català de la Salut, 08007 Barcelona, SpainBackground: Information regarding short-term vital prognosis in patients with heart failure at advanced stages of the disease is scarce. Objective: To develop a three-month mortality predictive model for patients with advanced heart failure. Methods: Prospective observational study carried out in primary care and a convalescence community facility. Heart failure patients either New York Heart Association (NYHA) III with at least two HF hospitalizations during the previous six months or NYHA IV with/without previous recent hospitalization were included in the study. Multivariable predictive models using Cox regression were performed. Results: Of 271 patients included, 55 (20.3%) died during the first three months of follow-up. Mean age was 84.2 years (SD 8.3) and 59.8% were women. Predictive model including NT-proBNP had a C-index of 0.78 (95% CI 0.71; 0.85) and identified male gender, low body mass index, high potassium and NT-proBNP levels, and moderate-to-severe dependence for daily living activities (Barthel index < 40) as risk factors of mortality. In the model without NT-proBNP, C index was 0.72 (95% CI 0.64; 0.79) and, in addition to gender, body mass index, low Barthel index, and severe reductions in glomerular filtration rate showed the highest predictive hazard ratios for short-term mortality. Conclusions: In addition to age, male gender, potassium levels, low body mass index, and low glomerular filtration, dependence for activities of daily living add strong power to predict mortality at three months in patients with advanced heart failure.https://www.mdpi.com/2077-0383/11/9/2280heart failurecommunity settingpredictive modelmortalityshort term prognosisend of life
spellingShingle Miguel Angel Muñoz
Esther Calero
Julio Duran
Elena Navas
Susana Alonso
Nuria Argemí
Marta Casademunt
Patricia Furió
Elena Casajuana
Nuria Torralba
Nuria Farre
Rosa Abellana
José-Maria Verdú-Rotellar
On behalf of HADES Study
Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
Journal of Clinical Medicine
heart failure
community setting
predictive model
mortality
short term prognosis
end of life
title Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
title_full Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
title_fullStr Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
title_full_unstemmed Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
title_short Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
title_sort short term mortality in patients with heart failure at the end of life stages hades study
topic heart failure
community setting
predictive model
mortality
short term prognosis
end of life
url https://www.mdpi.com/2077-0383/11/9/2280
work_keys_str_mv AT miguelangelmunoz shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT esthercalero shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT julioduran shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT elenanavas shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT susanaalonso shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT nuriaargemi shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT martacasademunt shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT patriciafurio shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT elenacasajuana shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT nuriatorralba shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT nuriafarre shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT rosaabellana shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT josemariaverdurotellar shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy
AT onbehalfofhadesstudy shorttermmortalityinpatientswithheartfailureattheendoflifestageshadesstudy